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Background: Recent studies have demonstrated the deletion of the histidine-rich protein 2 (PfHRP2) gene (pfhrp2)
in field isolates of Plasmodium falciparum, which could result in false negative test results when PfHRP2-based rapid
diagnostic tests (RDTs) are used for malaria diagnosis. Although primary diagnosis of malaria in Honduras is
determined based on microscopy, RDTs may be useful in remote areas. In this study, it was investigated whether
there are deletions of the pfhrp2, pfhrp3 and their respective flanking genes in 68 P. falciparum parasite isolates
collected from the city of Puerto Lempira, Honduras. In addition, further investigation considered the possible
correlation between parasite population structure and the distribution of these gene deletions by genotyping
seven neutral microsatellites.
Methods: Sixty-eight samples used in this study, which were obtained from a previous chloroquine efficacy
study, were utilized in the analysis. All samples were genotyped for pfhrp2, pfhrp3 and flanking genes by PCR.
The samples were then genotyped for seven neutral microsatellites in order to determine the parasite
population structure in Puerto Lempira at the time of sample collection.
Results: It was found that all samples were positive for pfhrp2 and its flanking genes on chromosome 8.
However, only 50% of the samples were positive for pfhrp3 and its neighboring genes while the rest were either
pfhrp3-negative only or had deleted a combination of pfhrp3 and its neighbouring genes on chromosome 13.
Population structure analysis predicted that there are at least two distinct parasite population clusters in this
sample population. It was also determined that a greater proportion of parasites with pfhrp3-(and flanking gene)
deletions belonged to one cluster compared to the other.
Conclusion: The findings indicate that the P. falciparum parasite population in the municipality of Puerto Lempira
maintains the pfhrp2 gene and that PfHRP2-based RDTs could be considered for use in this region; however continued
monitoring of parasite population will be useful to detect any parasites with deletions of pfhrp2.
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Honduras has the highest burden of malaria and the
highest proportion of Plasmodium falciparum cases in
Central America [1,2], but is steadily progressing toward
malaria elimination. The number of malaria cases per
year in the country has dropped from approximately* Correspondence: vxu0@cdc.gov
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unless otherwise stated.35,000 in 2000 to approximately 6,400 cases in 2012 [3].
Less than 10% of malaria cases in Honduras are caused
by P. falciparum. Malaria diagnosis in the country is
primarily conducted by microscopic examination of
Giemsa-stained thick and thin blood smears. In recent
years, however, malaria rapid diagnostic tests (RDTs)
have become valuable tools for use in remote areas where
microscopy use may not be feasible or where microscopy
results would not be immediately available.
Malaria RDTs are immunochromatographic tests that
detect malaria parasite antigens. The majority of malariaal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Abdallah et al. Malaria Journal  (2015) 14:19 Page 2 of 9RDTs detect histidine-rich protein 2 (PfHRP2), which
is produced during the asexual blood stage of the P.
falciparum life cycle but not by other human malaria
parasite species, making PfHRP2-based RDTs species-
specific [4]. Malaria parasite lactate dehydrogenase
(pLDH) and aldolase are two other targets of some
commercial malaria RDTs; although these tests are
mostly pan-specific, recent modifications have improved
their ability to differentiate species with pLDH based
RDTs. Some PfHRP2-detecting RDTs are known to cross-
react with PfHRP3 [5]. PfHRP2 and PfHRP3 are structural
homologs [6], but their respective genes are located on
different chromosomes, with pfhrp2 found on chromo-
some 8 and pfhrp3 on chromosome 13.
Recently, it was reported that approximately 40% of
P. falciparum field isolates in the Peruvian Amazon
lacked pfhrp2. Furthermore, 70% of these parasites had
deleted pfhrp3 and 21.6% of them were negative for
both pfhrp2 and pfhrp3 [7]. Although such large scale
deletion of pfhrp2 has not been reported in other parts
of the world, occurrence of a few pfhrp2-negative para-
sites has been reported in Mali [8], Senegal [9] and
India [10].
Little is known about the extent of pfhrp2 and pfhrp3
deletions in P. falciparum parasites from Honduras,
which has the highest burden of malaria in Central
America [3]. It was important to monitor if pfhrp2-nega-
tive parasites were present in Honduran P. falciparum
populations because of the implications for the use of
malaria RDTs in this country for case management and
malaria elimination programs. The aim of this study
was to determine whether there was deletion of pfhrp2,
pfhrp3, and their respective flanking genes in natural
P. falciparum parasites collected in Honduras and to
investigate the possible effect of parasite population
structure on the distribution of these gene deletions.
Methods
Study site and sample collection
Sixty-eight P. falciparum samples that were collected
during a previous study conducted between September
2008 and September 2009 in the city of Puerto Lempira,
which is located in the province of Gracias a Dios,
Honduras, were available for this retrospective investi-
gation [11]. In the original study, filter paper blood
spots were collected from febrile patients between the
ages of six months and 60 years who had uncomplicated
P. falciparum mono-infection and had provided written
informed consent at the time of enrollment. These pa-
tients participated in a clinical trial to assess the efficacy
of chloroquine. Further information on the patients and
study has been published previously [11]. The study was
approved by the institutional ethical review committee
of the Ethics Committee of the Medical Sciences Facultyof the National Autonomous University of Honduras
(UNAH-IRB 00003070). Investigators from the Centers
for Disease Control and Prevention obtained institutional
permission to use these samples for the current study
under a non-research determination.
Extraction of parasite DNA
Genomic DNA was extracted from dried blood spots on
filter paper using the Qiagen™ kit (QIAGEN, Valencia CA)
according to the manufacturer’s instructions and resus-
pended in 150 μl elution buffer.
Confirmation of P. falciparum infection by PCR
In order to determine if there were sufficient quantities
and quality of DNA present in the samples collected, two
genes were amplified, 18s ribosomal RNA (18S rRNA) and
merozoite surface protein 2 (msp2), using established PCR
protocols [12]. An assumption was made that the suc-
cessful amplification of both genes was indicative of a
reasonable quantity and quality of DNA that would
allow for the amplification of pfhrp2, pfhrp3 and their
respective neighbouring genes. Therefore, only those
samples that successfully amplified for these two genes
were included for final analysis of pfhrp2 and pfhrp3
gene deletion. The PCR amplification of the 18S riboso-
mal RNA gene was performed using methods previously
described [12]. Primer sequences for this nested reac-
tion were as follows: 5′CCT GTT GTT GCC TTA AAC
TTC3′ and 5′TTA AAA TTG TTG CAG TTA AAA
CG3′ for the primary reaction and 5′ TTA AAC TGG
TTT GGG AAA ACC AA ATA TAT T 3′ and 5′ ACA
CAA TGA ACT CAA TCA TGA CTA CCC GTC 3′ for
the secondary reaction. Briefly, PCR reactions were per-
formed in 25 μl total volume containing 10× buffer, 4 mM
MgCl2, 200 μM dNTPs, 250 nM primers, 1.25 units of
Taq Polymerase (New England Biolabs, Ipswich, MA,
USA), and 1–3 μl of DNA template. After confirmation of
Plasmodium genus, species-specific primers were used to
confirm P. falciparum infection.
The msp2 gene was amplified using a previously de-
scribed method [13]. Briefly, a nested PCR reaction
was used in which primary amplification targeted a
conserved region of this gene and a secondary PCR
step that amplified a polymorphic region of msp2 (3D7
and FC27 families). The primer sequences for the pri-
mary reaction were 5′GAA GGT AAT TAA AAC ATT
GTC 3′ and 5′GAT GTT GCT GCT CCA CAG3′ and
5′GAG TAT AAG GAG AAG TAT G3′ and 5′CTA
GAA CCA TGA ATA TGT CC3′ for the secondary re-
action. Confirmatory PCR reactions for msp2 were per-
formed in 20 μl total volume containing 10× buffer
with MgCl2, 200 μM dNTPs, 250 nM primers, 1.25
units of Taq Polymerase (New England Biolabs, Ipswich,
MA, USA), and 1–3 μl of DNA template. When PCR
Abdallah et al. Malaria Journal  (2015) 14:19 Page 3 of 9amplification was not successful for either gene, it was
repeated to confirm the result. However, if the first two
PCR amplification results were discordant, the amplifi-
cation was performed a third time and the two concord-
ant results were scored as the final result.
Detection of pfhrp2, pfhrp3 and flanking genes by PCR
Nested PCR amplification of each of the fragments
spanning exon 1, the intron, and exon 2 of pfhrp2 and
pfhrp3 (Figure 1) were performed using the primers and
reaction conditions described in Table 1. The primers
listed in Table 1 were designed around highly conserved
regions flanking each of the genes of interest in order to
minimize the possibility of variation in amplification
due to gene polymorphisms. Genes immediately flank-
ing pfhrp2 upstream (MAL7P1.230) and downstream
(MAL7P1.228), and those flanking pfhrp3 upstream
(MAL13P1.475) and downstream (MAL13P1.485), were
also amplified using the primers and reaction conditions
described in Table 1.
Pfhrp2, pfhrp3 and flanking gene amplifications were
performed in 20 μl total volume consisting of 10× buffer
with 15 mM MgCl2, 200 μM dNTPs, 15 μM forward
and reverse primers, 0.69 units of Taq Polymerase
(Roche, F. Hoffman-LaRoche Ltd, Basel, Switzerland),
and 2 μl of DNA template. An in vitro cultured P. falcip-
arum parasite isolate from the Amazon region of Peru
was used as a positive control for all pfhrp2, pfhrp3, and
flanking gene amplification experiments. Cultured para-
site isolate Dd2 (5 ng/μL) was used as the negativeFigure 1 Schematic of (A) Pfhrp2 and (B) Pfhrp3 and their respective f
was obtained, pfhrp2 was located on chromosome 7 although in a recent
to Chromosome 8. Pfhrp3 was reported to be immediately flanked by the i
the gene fragments that were amplified.control for all PCR experiments on pfhrp2 and its
flanking genes because this isolate lacks all three genes
[14]. Dd2 was also used as a positive control for all the
PCR experiments on pfhrp3 and its flanking genes be-
cause it has retained these genes. Similarly, cultured
parasite isolate HB3 (5 ng/μL) from Honduras was used
as the negative control for all pfhrp3 and flanking gene
amplifications because all three genes are absent from
this isolate [6]. Additionally, HB3 was used as a positive
control for all PCR experiments on pfhrp2 and its
flanking genes because these genes were present in this
isolate.
Expected PCR product sizes are indicated in Table 1.
All PCR products were separated and visualized on a 2%
agarose gel. When there was a positive reaction, this
result was accepted without further repetition. When a
negative test result was obtained, the amplification was
repeated for confirmation. If the second result was con-
cordant with the first, this was accepted as the final re-
sult. However, if the second result was discordant with
the previous test result, the experiment was conducted a
third time. The two matching results out of three were
scored as the final result.
Prevalence of pfhrp2, pfhrp3 and flanking gene deletions
The prevalence of pfhrp2, pfhrp3, and flanking gene
deletions was determined by dividing the number of
isolates that had deleted the gene by the total number
of isolates determined to be positive for both 18S rRNA
and msp2.lanking genes. In PlasmoDB version 8.0, from which gene information
update of PlasmoDB this gene and its flanking genes were reassigned
ndicated genes, all of which are on Chromosome 13. Arrows indicate
Table 1 Primer sequences and PCR reaction conditions to amplify pfhrp2, pfhrp3 and their respective flanking genes
Gene Reaction Primer name Primer sequence Annealing temperature, X (°C) Expected amplicon size (bp)
PF3D7_0831900 (MAL7P1.230) Primary 230 F1 5′ GAT ATC ATT AGA AAA CAA GAG CTT AG 3′ 63 301
230R 5′ TAT CCA ATC CTT CCT TTG CAA CAC C 3′
Nested 230 F 5′ TAT GAA CGC AAT TTA AGT GAG GCA G 3′ 65
230R 5′ TAT CCA ATC CTT CCT TTG CAA CAC C 3′
PfHRP2 Exon 1–2, PF3D7_0831800 Primary 2E12F1 5′ GGT TTC CTT CTC AAA AAA TAA AG 3′ 55 228
2E12R1 5′ TCT ACA TGT GCT TGA GTT TCG 3′
Nested 2E12F 5′ GTA TTA TCC GCT GCC GTT TTT GCC 3′ 62
2E12R 5′ CTA CAC AAG TTA TTA TTA AAT GCG GAA 3′
PF3D7_0831700 (MAL7P1.228) Primary 228 F 5′ AGA CAA GCT ACC AAA GAT GCA GGT G 3′ 60 198
228R 5′ TAA ATG TGT ATC TCC TGA GGT AGC 3′
Nested 228 F1 5′ CCA TTG CTG GTT TAA ATG TTT TAA G 3′ 63
228R 5′ TAA ATG TGT ATC TCC TGA GGT AGC 3′
PF3D7_1372100, (MAL13P1.485) Primary 485 F 5′ TTG AGT GCA ATG ATG AGT GGA G 3′ 60 241
485R 5′ AAA TCA TTT CCT TTT ACA CTA GTG C 3′
Nested 485 F1 5′ GTT ACT ACA TTA GTG ATG CAT TC 3′ 59
485R 5′ AAA TCA TTT CCT TTT ACA CTA GTG C 3′
PfHRP3 Exon 1–2, PF3D7_1372200 Primary 3E12F1 5′ GGT TTC CTT CTC AAA AAA TAA AA 3′ 53 225
3E12R1 5′ CCT GCA TGT GCT TGA CTT TA 3′
Nested 3E12F 5′ ATA TTA TCG CTG CCG TTT TTG CT 3′ 62
3E12R 5′ CTA AAC AAG TTA TTG TTA AAT TCG GAG 3′
PF3D7_1372400 (MAL13P1.475) Primary 475 F 5′ TTC ATG AGT AGA TGT CCT AGG AG 3′ 55 212
475R 5′ TCG TAC AAT TCA TCA TAC TCA CC 3′
Nested 475 F 5′ TTC ATG AGT AGA TGT CCT AGG AG 3′ 61
475R1 5′ GGA TGT TTC GAC ATT TTC GTC G 3′
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To determine the population structure of P. falciparum
parasite samples, we genotyped samples using seven
neutral microsatellite markers used in previous studies
[15-18]. Since only a limited amount of DNA was avail-
able from the samples, we performed whole-genome
amplification of the samples using the Repli-G amplifi-
cation kit (Qiagen, Valencia CA). The whole genome
amplified samples were used for the amplification of
the following neutral microsatellite loci: TA1 and
TA109, both of which are located on chromosome 6;
poly α (chromosome 4); PfPK2 (chromosome 12) and
2490 (chromosome 10); C2M34 (chromosome 2) and
C3M69 (chromosome 3) loci. The amplification prod-
ucts were labeled with fluorescent dyes (FAM or HEX)
and their sizes assayed on an Applied Biosystems 3130 xl
sequencer. The fragments were then scored using
GeneMapper software v.3.7 (Applied Biosystems, Foster
City CA) with default microsatellite settings, where bands
smaller than 500 relative fluorescence units (rfu) were de-
fined as background. Samples for which we obtained no
amplification in some loci were re-analysed to complete
the microsatellite haplotype profiles. If a locus did not
amplify after two rounds of PCR, the result was recorded
as negative.
Heterozygosity estimate
Overall parasite genetic diversity was examined by using
neutral microsatellite data to calculate the microsatellite
locus-specific heterozygosity and number of alleles per
locus (A) in the Excel Microsatellite Toolkit. Any micro-
satellite locus that did not amplify was assigned a null
value (350) for the purpose of these calculations. To de-
termine locus-specific heterozygosity, we used the virtual
heterozygosity estimate (HE), defined as HE = [n/(n − 1)]
[1 − Σpi
2], where n is the number of isolates analysed
and pi is the frequency of the i-th allele in the population.
HE gives the average probability that a pair of alleles ran-
domly obtained from the population is different and the
values range between 0 and 1.
Cluster analysis
To determine the population structure of P. falciparum
isolates collected in Puerto Lempira, a Bayesian approach
was used to infer the number of genetically related clus-
ters (K) from the individual microsatellite profiles gener-
ated with the seven neutral microsatellites. Only samples
that were determined to be singly infected (based on
obtaining a single peak for each locus by neutral micro-
satellite analysis) were used for cluster analysis (N = 65).
The calculation was performed using Structure v2.3.3
[19] in which the likelihood of finding between one and
ten clusters in this population (K = 1 to K = 10) was
tested. Twenty replicates of the clustering algorithm foreach value of K were performed with a burn-in period
of 10,000 iterations and 100,000 Markov Chain Monte
Carlo replications, using the admixture model with
correlated allele frequencies [20]. The most likely
number of clusters was defined by calculating the ΔK
value as described by Evanno et al. [21] and results from
Structure were entered into the Structure Harvester
program [22].
Analysis of genetic distance
Population pairwise FST calculations were performed in
Arlequin v3.11 [23]. The exact test of population differenti-
ation was used with 1000 permutations and a significance
level of 0.05.
Results
Analysis of pfhrp2 and flanking genes
All 68 P. falciparum parasite isolates from Honduras
were initially tested for the presence of 18S rRNA and
msp2 and showed positive amplification, confirming the
presence of good quality DNA. Pfhrp2 and its flanking
genes, MAL7P1.230 and MAL7P1.228, were found to be
present in all parasite isolates.
Analysis of pfhrp3 and flanking genes
Thirty out of 68 isolates (44.1%) tested negative for
the pfhrp3 gene while 32 isolates (47.1%) showed dele-
tion of the Mal13P1.475 gene that is located upstream
of pfhrp3 (Figure 2). Thirteen isolates had deleted the
Mal13 P1.485 gene, located downstream of pfhrp3
(Figure 2).
Thirty-four samples tested were positive for both
pfhrp3 and its flanking genes. One pfhrp3-positive isolate
had deleted both flanking genes (Table 2). Forty-four per-
cent of the parasite isolates tested were pfhrp3-negative
and had additionally deleted either MAL13P1.475 or
MAL13P1.485: 26.5% of the isolates were pfhrp3/
MAL13P1.475 double-negative while 3% of the isolates
were pfhrp3/MAL13P1.485 double-negative (Table 2).
Approximately 15% of the parasite isolates had deleted
all three genes (Table 2).
Microsatellite genotyping and cluster analysis
We performed neutral microsatellite genotyping and
cluster analysis to determine if the population structure
correlated with pfhrp3-deleted parasites. Structure analysis
predicted the presence of at least two clusters of parasites
(K = 2; Figure 3). Twenty-seven samples belonged to the
first cluster (designated Cluster 1) while 37 were assigned
to Cluster 2 (Figure 3). One isolate belonging to Cluster 1
was MAL13P1.475-negative (3.7%), six were MAL13P1.475/
pfhrp3-negative (22.2%) and one had deleted all three
genes (3.7%) (Table 2). Among the samples assigned to








Figure 2 Prevalence of deletions in pfhrp3 and neighboring genes in P. falciparum isolates from Puerto Lempira, Nicaragua. The
map shows the location of Honduras in relation to neighboring countries in Central America. All parasite isolates analysed were found to be
positive for pfhrp2 and its flanking genes (not shown). The three pie charts shown illustrate the proportion of parasite isolates with deletions
in pfhrp3 and its neighboring genes. The percentages shown represent proportions of samples out of the total samples that were 18S
rRNA- and msp2-positive.
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while eight were MAL13P1.475/pfhrp3/MAL13P1.485
triple-negative (21.6%) (Table 2). In order to assess
genetic differentiation due to population substructure,
pair-wise Fst values were calculated, and found that
Clusters 1 and 2 presented moderate genetic differenti-
ation (0.12146; p-value < 0.05).Table 2 Deletion pattern of Pfhrp3 and its flanking genes in t










The symbol ‘+’ indicates gene amplification while ‘-’ indicates no gene amplification
included in the population cluster analysis using Structure v2.3.3. Three samples we
microsatellite loci, indicating possible multiple strain infection. The columns labeled
proportions) of samples with the indicated MAL13P1.475/ Pfhrp3/ MAL13P1.485 gen
identified using Structure v2.3.3.Genetic diversity
HE, a measure of genetic variation at each locus, was be-
tween 0.2 and 0.7 with relatively few allelic forms of each
marker (A) identified (Table 3). This is indicative of low
genetic diversity in this parasite population. The number
of alleles per locus in this population ranged from three
to five (Table 4).wo population clusters
All samples, N (%) Cluster 1 Cluster 2
34 (50%) 19 (70.4%) 13 (35.1%)
0 (0%) 0 (0.0%) 0 (0.0%)
3 (4.4%) 1 (3.7%) 2 (5.4%)
2 (2.9%) 0 (0.0%) 2 (5.4%)
18 (26.5%) 6 (22.2%) 12 (32.4%)
10 (14.7%) 1 (3.7%) 8 (21.6%)
0 (0%) 0 (0.0%) 0 (0.0%)
1 (1.5%) 0 (0.0%) 1 (2.7%)
68 27* 38*
after two attempts. N – number of samples. *A total of 65 samples were
re excluded because more than one allele was amplified in one or more
‘Cluster 1’ and ‘Cluster 2’ show the absolute numbers (and percentage
e profiles that were assigned to each of the two parasite population clusters
Cluster 1 Cluster 2
Figure 3 Bayesian cluster analysis of P. falciparum singly-infected samples collected from Puerto Lempira, Honduras (N = 65). The
predicted number of likely clusters (K) for the samples was K = 2. Each color corresponds to a population cluster as classified by Structure v2.3.3,
and each individual isolate is represented by a vertical bar. The Y axis represents the estimated proportion of membership of an individual to
each population.
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Recent reports of pfhrp2 gene deletions in natural P.
falciparum isolates from Peru and other countries have
highlighted the importance of molecular surveillance
to detect these deletions because they could lead to
false-negative diagnoses when using PfHRP2-based
malaria RDTs [7,8]. Per common knowledge, this may
be the first report to document the prevalence of
pfhrp2 and pfhrp3 genes in natural P. falciparum isolates
in Honduras. The approach taken in this study involved
PCR amplification of the genes of interest (pfhrp2 and
pfhrp3) and their flanking genes in order to estimate the
extent of deletion around pfhrp2 and pfhrp3.
The data from this study showed no deletions of pfhrp2
or its flanking genes (MAL7P1.228 and MAL7P1.230) in
the samples tested, suggesting that the region on chromo-
some 8 spanning pfhrp2 was intact in P. falciparum para-
sites in Puerto Lempira in 2008–2009. This data is similar
to recent observations from French Guiana where no de-
letion of pfhrp2 gene was found [24]. On the contrary,
pfhrp3 deletion was found in about 44% of the samples
tested (Figure 2). Different combinations of deletion
profiles for MAL13P1.475, pfhrp3 and MAL13P1.485
were observed. The majority of pfhrp3-negative para-
sites were also either negative for the downstream gene
MAL13P1.475 (~27%) or for both flanking genes (~15%)Table 3 Microsatellite diversity for seven P. falciparum neutra
Microsatellite marker name TA1 Polyα PfP
Chromosome 6 4 12
Allelic size range, bp 74–190 138–180 160
No. of alleles per locus (A) 4 5 3
PCR positivity* 60 65 64
HE 0.650 0.687 0.53
The microsatellite markers shown are described in the Methods section. bp – base
samples that were successfully amplified for the indicated loci (out of a total of 68
the number of samples. It is defined as the probability that a randomly chosen pair(Table 2). The highest prevalence of pfhrp3-negative para-
sites was reported in Peru, reaching as high as 70% [7]. In
French Guiana, the prevalence of pfhrp3-negative parasite
isolates was only 4.5% [24]. Previous research showed that
pfhrp3 deletions in the laboratory parasite line HB3, which
is a Honduran parasite isolate, resulted from chromosomal
deletions of a large genomic fragment in chromosome 13
[25,26]. Another study hypothesized that the deletion of
pfhrp3 in HB3 may have occurred as a result of the duplica-
tion and translocation of a region of chromosome 11 onto
chromosome 13 [27]. It was not clear if pfhrp3 was deleted
before or after the HB3 strain was adapted to in vitro cul-
ture. Based on the results of this study, it can be speculated
that pfhrp3 deletion may have occurred in HB3 even before
it was adapted to in vitro culture because these observa-
tions show it in naturally occurring parasite populations in
Honduras.
Population structure analysis showed two major clusters
of parasites. This low level of diversity is consistent with a
recent study that showed similar results when comparing
P. falciparum isolates from different municipalities in
Honduras (including Puerto Lempira) and Nicaragua [28].
In this study, pfhrp3 deleted parasites were observed in
both clusters. In the study conducted by Larranaga et al.,
Bayesian cluster analysis predicted that most of the iso-
lates collected from mainland Honduras belonged to al microsatellite markers
k2 TA109 2490 C2M33 C3M69
6 10 2 3
–192 188–200 80–84 140–228 122–138
2 2 5 5
62 60 64 65
1 0.550 0.469 0.256 0.636
pairs; PCR – Polymerase chain reaction. *PCR positivity indicates the number of
samples). HE – virtual heterozygosity where HE = [n/(n–1)] × (1-Σp
2i), and n is
of alleles differ from each other.
Table 4 Allelic frequencies at the seven P. falciparum
microsatellite loci analysed
Microsatellite locus Allele sizes (bp) N Frequency














TA109 188 29 0.45
200 33 0.51
DNW 3 0.05
2490 80 15 0.23
84 45 0.69
DNW 5 0.08











DNW – Samples that did not amplify an allele at the indicated locus.
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come of the analysis may have been different if cluster
analysis had been performed on the samples from
Honduras alone rather than including isolates from
Nicaragua [28]. Furthermore, these results indicate that
there is still some level of substructure present (Figure 3)
in this population. Nevertheless, a greater number of
samples including complete haplotype information would
be needed to draw further conclusions. The area in
which Puerto Lempira is located accounted for nearly
68% (419/610) of P. falciparum cases reported in
Honduras in 2008 (the year in which sample collection
started for this study).One limitation of this study is that all samples were
collected from one location and only within a one-year
period; further testing would need to be conducted on P.
falciparum isolates collected from various geographical
regions of Honduras in order to confirm that the current
findings are applicable to the entire country. It should
be noted, however, that most of Honduras reports very
few malaria cases annually and Puerto Lempira is one of
the areas where RDTs need to be used for programmatic
purposes due to limited access to microscopy [3]. As such,
PfHRP2 surveillance in Central America should continue
in order to monitor the pattern of distribution of pfhrp2
and pfhrp3 deletions.
Central America has relatively low levels of malaria
transmission compared to most of the malarious regions
of South America. RDTs are especially useful in areas
where there is limited access to microscopy for malaria
surveillance and elimination programs. In Honduras, both
P. falciparum and P. vivax transmission occur and al-
though microscopy is used as a primary diagnostic test for
case management, RDTs are useful in remote areas where
access to microscopic diagnosis is limited. To detect both
P. falciparum and P. vivax, RDT combination tests that
can detect both species are recommended. In this context,
these finding suggests that pfhrp2-negative parasites
have not evolved or spread in Honduras and that
PfHRP2-based RDTs can still be considered for use in this
region as part of the combination tests for P. falciparum
and P. vivax diagnosis.
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